MedPage Today August 27, 2024
— SmartAdjust technology is used in Insulet’s Omnipod 5 Automated Insulin Delivery System
The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday.
An interoperable automated glycemic controller, Insulet’s SmartAdjust technology is software that automatically adjusts insulin delivery by connecting to an alternate controller-enabled insulin pump and integrated continuous glucose monitor.
Used in Insulet’s tubeless Omnipod 5 Automated Insulin Delivery (AID) System, the technology eliminates the need for multiple daily injections by automatically adjusting insulin delivery every 5 minutes.
“The FDA has long worked with the diabetes community to ensure access to additional options and flexibilities for diabetes management,” said Michelle Tarver, MD, PhD, acting director of the FDA’s Center...
Today's Sponsors
Today's Sponsor